Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs
Boehringer taps RetinAI for AI boost to eye disease R&D
Report names connected medical devices with the biggest cybersecurity risks
Big pharma holds steady on research spending
*please scroll down for all the latest news*
